
CPHI & PMEC China 2026
06/2026 – 06/2026
Founded in June 2020, Zhejiang Zerui Biopharma Co., Ltd. is a forward-looking, high-tech enterprise specializing in advancing Semaglutide (CAS 910463-68-2) along with its main chain peptide sequence (9-37) (CAS 1169630-82-3) and side chain tBuO-Ste-Glu(AEEA-AEEA-OH)OtBu (CAS 1118767-16-0).

Chưa có bình luận nào.
Để lại đánh giá & nhận xét